NovoCure Ltd Insider Trading for August 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for August 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | J | 97.80 | 13,835 | 1,353,063 | 63,141 | 77 K to 63.1 K (-17.97 %) |
| Aug 06 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 85.23 | 1,813 | 154,522 | 76,976 | 78.8 K to 77 K (-2.30 %) |
| Aug 02 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,718 | 0 | 7,434 | |
| Aug 02 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 34.00 | 5,115 | 173,910 | 15,343 | |
| Aug 02 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 83.20 | 1,905 | 158,502 | 78,789 | 80.7 K to 78.8 K (-2.36 %) |
| Aug 02 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 83.30 | 3,718 | 309,709 | 80,694 | 77 K to 80.7 K (+4.83 %) |
| Aug 02 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 82.92 | 5,115 | 424,136 | 76,976 | 82.1 K to 77 K (-6.23 %) |
| Aug 02 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 34.00 | 5,115 | 173,910 | 82,091 | 77 K to 82.1 K (+6.64 %) |
| Aug 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | A | 83.30 | 10,412 | 867,320 | 10,412 | |
| Aug 01 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Grant | A | 0.00 | 6,002 | 0 | 852,465 | 846.5 K to 852.5 K (+0.71 %) |
| Aug 01 2019 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Option Exercise | A | 83.30 | 5,206 | 433,660 | 5,206 | |
| Aug 01 2019 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Grant | A | 0.00 | 3,001 | 0 | 15,617 | 12.6 K to 15.6 K (+23.79 %) |